Swiss National Bank
SNDX icon

Swiss National Bank’s Syndax Pharmaceuticals SNDX Stock Holding History

Swiss National Bank’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.77M Hold
161,400
– – ﹤0.01% 1509
2025
Q4 		$3.39M Buy
161,400
+2,900
+2% +$50.6K ﹤0.01% 1585
2025
Q3 		$2.44M Sell
158,500
-5,800
-4% -$75.9K ﹤0.01% 1754
2025
Q2 		$1.54M Buy
164,300
+14,900
+10% +$164K ﹤0.01% 1939
2025
Q1 		$1.84M Hold
149,400
– – ﹤0.01% 1817
2024
Q4 		$1.98M Hold
149,400
– – ﹤0.01% 1863
2024
Q3 		$2.88M Sell
149,400
-1,200
-0.8% -$24.8K ﹤0.01% 1649
2024
Q2 		$3.09M Hold
150,600
– – ﹤0.01% 1571
2024
Q1 		$3.58M Buy
150,600
+8,200
+6% +$183K ﹤0.01% 1507
2023
Q4 		$3.08M Buy
142,400
+21,400
+18% +$329K ﹤0.01% 1600
2023
Q3 		$1.76M Buy
121,000
+1,700
+1% +$32.2K ﹤0.01% 1920
2023
Q2 		$2.5M Buy
119,300
+3,600
+3% +$75K ﹤0.01% 1743
2023
Q1 		$2.44M Sell
115,700
-13,700
-11% -$341K ﹤0.01% 1716
2022
Q4 		$3.29M Buy
129,400
+16,100
+14% +$376K ﹤0.01% 1570
2022
Q3 		$2.72M Buy
113,300
+8,100
+8% +$182K ﹤0.01% 1662
2022
Q2 		$2.02M Buy
105,200
+11,800
+13% +$197K ﹤0.01% 1910
2022
Q1 		$1.62M Buy
93,400
+8,100
+9% +$136K ﹤0.01% 2151
2021
Q4 		$1.87M Hold
85,300
– – ﹤0.01% 2110
2021
Q3 		$1.63M Buy
85,300
+2,200
+3% +$36.7K ﹤0.01% 2181
2021
Q2 		$1.43M Buy
83,100
+9,000
+12% +$165K ﹤0.01% 2303
2021
Q1 		$1.66M Buy
74,100
+900
+1% +$20.3K ﹤0.01% 2119
2020
Q4 		$1.63M Buy
+73,200
New +$1.52M ﹤0.01% 2026

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Swiss National Bank's SNDX Position: Q1 2026 in Review

Swiss National Bank held its Syndax Pharmaceuticals (SNDX) position steady in Q1 2026 at 161,400 shares worth $3.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1509.

Swiss National Bank first reported a position in SNDX in Q4 2020 and has held it in 22 quarters since. 247 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Swiss National Bank held 161,400 shares of Syndax Pharmaceuticals worth $3.77M as of Q1 2026.
  • Swiss National Bank left its Syndax Pharmaceuticals share count unchanged in Q1 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1509 holding.
  • Swiss National Bank first reported a position in Syndax Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • 247 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.